EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H34N5O10.Gd |
| Net Charge | 0 |
| Average Mass | 661.767 |
| Monoisotopic Mass | 662.15467 |
| SMILES | COCCNC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-].[Gd+3] |
| InChI | InChI=1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3 |
| InChIKey | HBEAOBRDTOXWRZ-UHFFFAOYSA-K |
| Wikipedia |
|---|
| Roles Classification |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| gadoversetamide (CHEBI:31644) has role MRI contrast agent (CHEBI:37335) |
| gadoversetamide (CHEBI:31644) is a gadolinium coordination entity (CHEBI:35730) |
| IUPAC Name |
|---|
| gadolinium 8,11-bis(carboxylatomethyl)-14-{2-[(2-methoxyethyl)amino]-2-oxoethyl}-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oate |
| Synonym | Source |
|---|---|
| gadoversetamide | ChemIDplus |
| Brand Name | Source |
|---|---|
| OptiMARK | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| D01646 | KEGG DRUG |
| Gadoversetamide | Wikipedia |
| DB00538 | DrugBank |
| Registry Numbers | Sources |
|---|---|
| Gmelin:1701622 | Gmelin |
| Reaxys:11736544 | Reaxys |
| CAS:131069-91-5 | ChemIDplus |